HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
The move would cut costs for Medicare and save beneficiaries millions of dollars, according to an article in The New York Times.
Under a demonstration project in half the country, Medicare would create and use an “international pricing index” to decide how much to pay for drugs covered by Part B of Medicare.
A recently released study by the U.S. Department of Health and Human Services revealed that Medicare paid 80 percent more than other advanced industrial countries for some of the most expensive prescription medicines, The Times reported.
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus .jpg)
Recommendations Updated for Management of Anemia in CKD .jpg)
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds 
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health 
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
